Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities

Cell Reports(2022)10.1016/j.celrep.2022.110448Source: DataRank Database

CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 134 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access134 citations

Download PDF

Cite:

Linked data & code

cellosaurus

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)OA: goldTopics (30)Linked Datasets (10)DataCite Reuse (10)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Vishnu Kumarasamy ORCID,Ram Nambiar,Joel D. Pearson ORCID,Paris Vail,Hanna R. Rosenheck

Live enrichment

PubMed:35235778 PMC:PMC9022184

NCI NIH HHS

Grant: R01 CA228413

NCI NIH HHS

Grant: P30 CA016056

NCI NIH HHS

Grant: R01 CA211878

NCI NIH HHS

Grant: R01 CA247362

NIH HHS

Grant: S10 OD027012

NCI NIH HHS

Grant: R01 CA267647

NCI NIH HHS

Grant: P30 CA042014

National Institutes of Health

Grant: 5R01CA211878-03

Common Genetically Altered Pathways as Targets for Therapy in Pancreatic Cancer

National Institutes of Health

Grant: 3P30CA042014-30S2

Cancer Center Support Grant

National Institutes of Health

Grant: 3R01CA247362-05S1

RB tumor suppressor as a therapeutic target in ER-positive breast cancer

National Institutes of Health

Grant: 5P30CA016056-40

Roswell Park Cancer Institute Cancer Center Support Grant

Influential Citations

goldLicense: cc-by-nc-nd

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022184

publisherhttps://doi.org/10.1016/j.celrep.2022.110448

publisherhttps://api.elsevier.com/content/article/PII:S2211124722001759?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124722001759?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9022184

Fields of Study

MedicineBiology0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

HumansNeoplasmsCyclin-Dependent KinasesCell Cycle ProteinsCell CycleCell DivisionCyclin-Dependent Kinase Inhibitor p27Cyclin-Dependent Kinase 4

Keywords

CyclinCDKE2Fp27rbp16Cyclin Ecyclin D1NeoplasmsCell CycleCyclin-Dependent Kinase 4HumansCell Cycle ProteinsArticleCell DivisionCyclin-Dependent Kinase Inhibitor p27Cyclin-Dependent Kinases

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of AGA induces sub-G1 cell cycle arrest and apoptosis in human colon cancer cells through p53-independent/p53-dependent pathway

10.6084/m9.figshare.22612901.v1figshare

Additional file 1 of AGA induces sub-G1 cell cycle arrest and apoptosis in human colon cancer cells through p53-independent/p53-dependent pathway

10.6084/m9.figshare.22612901figshare

Additional file 1 of Tetrastigma hemsleyanum (Sanyeqing) root extracts evoke S phase arrest while inhibiting the migration and invasion of human pancreatic cancer PANC-1 cells

10.6084/m9.figshare.25495168.v1figshare

Additional file 1 of Tetrastigma hemsleyanum (Sanyeqing) root extracts evoke S phase arrest while inhibiting the migration and invasion of human pancreatic cancer PANC-1 cells

10.6084/m9.figshare.25495168figshare

Additional file 2 of Tetrastigma hemsleyanum (Sanyeqing) root extracts evoke S phase arrest while inhibiting the migration and invasion of human pancreatic cancer PANC-1 cells

10.6084/m9.figshare.25495266.v1figshare

Additional file 2 of Tetrastigma hemsleyanum (Sanyeqing) root extracts evoke S phase arrest while inhibiting the migration and invasion of human pancreatic cancer PANC-1 cells

10.6084/m9.figshare.25495266figshare

Additional file 3 of Tetrastigma hemsleyanum (Sanyeqing) root extracts evoke S phase arrest while inhibiting the migration and invasion of human pancreatic cancer PANC-1 cells

10.6084/m9.figshare.26698733.v1figshare

Additional file 3 of Tetrastigma hemsleyanum (Sanyeqing) root extracts evoke S phase arrest while inhibiting the migration and invasion of human pancreatic cancer PANC-1 cells

10.6084/m9.figshare.26698733figshare

Additional file 1 of Association of CCND1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study

10.6084/m9.figshare.25566289figshare

Additional file 1 of Association of CCND1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study

10.6084/m9.figshare.25566289.v1figshare

CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities

FAIR Checklist

Authors (13)

Funding (11 grants)

Impact

Open Access

Topics

Linked Datasets (10)

Annotations (Europe PMC)